Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gestational trophoblastic disease.

John T Soper1

  • 1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina 27710, USA. soper001@mc.duke.edu

Obstetrics and Gynecology
|July 4, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Review of Current Management of Placental Site Trophoblastic Tumor and Epithelioid Trophoblastic Tumor.

Obstetrical & gynecological survey·2022
Same author

Vulvar Intraepithelial Neoplasia: A Review of the Disease and Current Management.

Obstetrical & gynecological survey·2021
Same author

Gestational Trophoblastic Disease: Current Evaluation and Management.

Obstetrics and gynecology·2021
Same author

GOG 244 - The Lymphedema and Gynecologic cancer (LeG) study: The impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability, and function.

Gynecologic oncology·2020
Same author

Defining the learning curve for successful staging with sentinel lymph node biopsy for endometrial cancer among surgeons at an academic institution.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2020
Same author

Physical Activity: Impact on Survival in Gynecologic Cancer.

Obstetrical & gynecological survey·2019
Same journal

The Political Determinants of Obstetric Prescribing.

Obstetrics and gynecology·2026
Same journal

Glucagon-Like Peptide-1 Receptor Agonists and Risk of Adverse Maternal Pregnancy Outcomes: A Systematic Review and Meta-analysis.

Obstetrics and gynecology·2026
Same journal

Milestones in Motion: Vaginal Birth After Cesarean.

Obstetrics and gynecology·2026
Same journal

Ebola Virus in Pregnancy.

Obstetrics and gynecology·2026
Same journal

A Quality-Improvement Study Evaluating Three Postpartum Prophylactic Oxytocin Rates and Blood Loss After Vaginal Birth.

Obstetrics and gynecology·2026
Same journal

The Effects of Climate Change on Obstetric and Gynecologic Health.

Obstetrics and gynecology·2026
See all related articles

This review covers molar pregnancy management and malignant gestational trophoblastic neoplasia (GTN) care. Proper management preserves reproductive function and ensures prompt identification and treatment of GTN.

Area of Science:

  • Gynecology
  • Obstetrics
  • Oncology

Background:

  • Molar pregnancies require careful management to prevent complications.
  • Gestational trophoblastic neoplasia (GTN) can arise after molar pregnancy.
  • Timely diagnosis and treatment are crucial for favorable outcomes.

Purpose of the Study:

  • To review the primary management of molar pregnancies.
  • To outline surveillance protocols post-evacuation.
  • To detail the evaluation and treatment of malignant GTN.

Main Methods:

  • Literature review of current management strategies.
  • Analysis of International Federation of Gynecology and Obstetrics (FIGO) guidelines.
  • Discussion of risk stratification and individualized treatment approaches for GTN.

Related Experiment Videos

Main Results:

  • Most molar pregnancies are managed successfully, preserving reproductive function.
  • Effective surveillance can identify malignant sequelae early.
  • Individualized treatment based on risk factors improves outcomes for malignant GTN.

Conclusions:

  • Proper molar pregnancy management minimizes acute risks and aids early GTN detection.
  • FIGO guidelines provide a standardized approach to GTN diagnosis and staging.
  • Personalized, expert-guided treatment is essential for managing malignant GTN effectively.